EMA, like FDA, says testosterone-raising drugs are not for lifestyle use

Eric Palmer

The European Medicines Agency has thrown more cold water on sales of testosterone-raising meds as a party drug for aging men. The agency said today that the evidence is inconsistent about the cardio risks of the , but they should only be reserved to treat men whose level is low because of a medical condition.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS